⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKBA News
Akebia Therapeutics, Inc.
Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights
globenewswire.com
AKBA
U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week
globenewswire.com
AKBA
Form 8-K
sec.gov
AKBA
Form 8-K
sec.gov
AKBA
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
globenewswire.com
AKBA
Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026
globenewswire.com
AKBA
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases
globenewswire.com
AKBA
Focal Segmental Glomerulosclerosis (FSGS) Market Insights, Epidemiology and Forecast 2026-2036 - Targeted Therapies Reshape Treatment Through 2036
globenewswire.com
TARA
AMTX
AKBA
APLS
NVS
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA